Droguerre M

References (3)

Title : Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model - Vidal_2022_J.Psychopharmacol__2698811221128963
Author(s) : Vidal B , Pereira M , Valdebenito M , Vidal L , Mouthon F , Zimmer L , Charveriat M , Droguerre M
Ref : J Psychopharmacol , :2698811221128963 , 2022
Abstract :
PubMedSearch : Vidal_2022_J.Psychopharmacol__2698811221128963
PubMedID: 36205074

Title : Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer's Disease - Droguerre_2020_Front.Neurosci_14_563
Author(s) : Droguerre M , Duchene A , Picoli C , Portal B , Lejards C , Guiard BP , Meunier J , Villard V , Deglon N , Hamon M , Mouthon F , Charveriat M
Ref : Front Neurosci , 14 :563 , 2020
Abstract :
PubMedSearch : Droguerre_2020_Front.Neurosci_14_563
PubMedID: 32612499

Title : Pharmaco-fUS for Characterizing Drugs for Alzheimer's Disease - The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine - Vidal_2020_Front.Neurosci_14_835
Author(s) : Vidal B , Droguerre M , Valdebenito M , Zimmer L , Hamon M , Mouthon F , Charveriat M
Ref : Front Neurosci , 14 :835 , 2020
Abstract :
PubMedSearch : Vidal_2020_Front.Neurosci_14_835
PubMedID: 32903470